About Us
Management
Board of Directors
Investors
Products
Overview
LUM001
LUM002
Patients & Caregivers
Cholestatic Liver Disease
Alagille Syndrome
Progressive Familial Intrahepatic Cholestasis
Primary Biliary Cirrhosis
Primary Sclerosing Cholangitis
News & Events
Contact Us
Welcome
At Lumena Pharmaceuticals we’re passionate about providing better treatment options for adults and children who are suffering from rare and debilitating liver diseases. That’s why we’re focused on developing oral therapeutics that improve liver function, relieve disease symptoms and dramatically impact patient health.
Read More
Their Stories
Real-life stories of patients with cholestatic liver disease.
Read More
Company News
Lumena Announces $23 Million Series A Financing
Press Release